Acute hypotensive, natriuretic, and hormonal effects of nifedipine in salt-sensitive and salt-resistant black normotensive and hypertensive subjects

被引:9
作者
Damasceno, A
Santos, A
Pestana, M
Serrao, P
Caupers, P
Soares-da-Silva, P
Polónia, J [1 ]
机构
[1] Fac Med Porto, Unidade Farmacol Clin, P-4200 Oporto, Portugal
[2] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique
[3] Fac Med Porto, Unidade Nefrol, P-4200 Oporto, Portugal
[4] Fac Med Porto, Inst Farmacol & Terapeut, P-4200 Oporto, Portugal
关键词
hypertension in blacks; salt-sensitive; salt-resistant; nifedipin; natriuresis; dopaminergic system; renin; aldosterone; ambulatory monitoring;
D O I
10.1097/00005344-199909000-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a randomized double-blind study, we compared the short-term effects of nifedipine (10 mg 3 x daily for 1 day) versus placebo on 24-h blood pressure, diuresis, natriuresis, urinary excretion of dopamine and metabolites, and on plasma renin activity (PRA) and plasma aldosterone levels in 18 black hypertensive (HT) patients [eight salt-resistant (HT-SR) and 10 salt-sensitive (HT-SS)], and in 20 black normotensive (NT) subjects (12 NT-SR and eight NT-SS) who were studied randomly with both a high- (HS) and a low-salt (LS) diet. In comparison to placebo, nifedipine significantly decreased 24-h mean BP in all groups either with HS or LS diets (all p < 0.05). With HS, greater hypotensive effects were achieved in WT-SS (-10 +/- 2 mm Hg) versus NT-SR (-3 +/- 1 mm Hg; p < 0.05) and in WT-SS (-18 +/- 2 mm Hg) versus MT-SR (-12 +/- 2 mm Hg; p < 0.05). In NT-SS and HT-SS. nifedipine induced greater (p < 0.05) BP decrease with HS (-10 +/- 2 and -18 +/- 2 mm Hg) than with LS (-3 +/- 1 and -9 +/- 1 mm Hg, respectively), whereas in NT-SR and MT-SR, the hypotensive effect did not differ between HS and LS. Nifedipine versus placebo significantly increased natriuresis and fractional excretion of sodium in all groups only with HS (p < 0.05) but not with LS diets. Only in HT-SS were the hypotensive and natriuretic effects of nifedipine significantly correlated (r = -0.77; p < 0.01). Nifedipine produced a similar increase of the urinary excretion of dopamine, L-DOPA, and of DOPAC in all subjects, which did not correlate with hypotensive and natriuretic effects. Nifedipine did not modify plasma levels of renin and of aldosterone except in NT-SS with HS, in whom nifedipine increased PRA levels (p < 0.05). We conclude that although nifedipine reduces BP in all groups of NT and HT with LS and I-IS diets, the effect is greater in salt-sensitive subjects with HS. Although in HT-SS with HS, the short-term natriuretic response to nifedipine may contribute to its hypotensive effects, the diuretic-natriuretic effect of nifedipine is not necessary for the expression of its hypotensive effect. Moreover, it is unlikely that any short-term effects of nifedipine either on the renal dopaminergic system or on the secretion of aldosterone explain nifedipine short-term hypotensive and diuretic-natriuretic effects.
引用
收藏
页码:346 / 353
页数:8
相关论文
共 40 条
[1]   EFFECTS OF DIETARY SODIUM AND OF ACUTE SALINE INFUSION ON INTERRELATIONSHIP BETWEEN DOPAMINE EXCRETION AND ADRENERGIC ACTIVITY IN MAN [J].
ALEXANDER, RW ;
GILL, JR ;
YAMABE, H ;
LOVENBERG, W ;
KEISER, HR .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (01) :194-200
[2]   EFFECT OF DIETARY-SODIUM INTAKE ON INTRACELLULAR CALCIUM IN LYMPHOCYTES OF SALT-SENSITIVE HYPERTENSIVE PATIENTS [J].
ALEXIEWICZ, JM ;
GACIONG, Z ;
PARISE, M ;
KARUBIAN, F ;
MASSRY, SG ;
CAMPESE, VM .
AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (08) :536-541
[3]   EFFECT OF SODIUM-BALANCE AND CALCIUM CHANNEL-BLOCKING DRUGS ON PLASMA-ALDOSTERONE RESPONSES TO INFUSION OF ANGIOTENSIN-II IN NORMAL SUBJECTS AND PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
ANDERSON, GH ;
HOWLAND, T ;
DOMSCHEK, R ;
STREETEN, DHP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (05) :1126-1135
[4]  
Blaustein M. P., 1977, AM J PHYSIOL, V1, P165
[5]  
Borges N, 1993, Rev Port Cardiol, V12, P313
[6]   The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure [J].
Campo, C ;
Garcia-Vallejo, O ;
Barrios, V ;
Lahera, V ;
Manero, M ;
Esteban, E ;
Rodicio, JL ;
Ruilope, LM .
JOURNAL OF HYPERTENSION, 1997, 15 (12) :1803-1808
[7]  
CAPPUCCIO FP, 1987, J CARDIOVASC PHARM, V10, pS57, DOI 10.1097/00005344-198710100-00021
[8]  
CAPPUCCIO FP, 1994, J HUM HYPERTENS, V8, P627
[9]  
CONWAY J, 1990, J HYPERTENS S6, V8, P83
[10]  
DEMASCENO A, 1999, REV PORT CARDIOL, V18, P9